Last edition
News about "CAR T-cell therapy "
CARsgen Initiates Investigator-Initiated Trial for Allogeneic CD19/CD20 CAR-T Therapy
KJ-C2219 is developed based on CARsgen's THANK-u Plus platform and is designed for the treatment of hematologic malignancies and autoimmune diseases.
CAR T-cell Therapy | 02/01/2025 | By Aishwarya
Biosyngen Gets FDA Approval for BRG01 for Phase II Clinical Trial
Biosyngen has announced that the US Food and Drug Administration (FDA) has approved its BRG01, an EBV-specific CAR-T cell therapy, to proceed with a pivotal Phase lI clinical trial.
CAR-T Cell Therapy | 13/08/2024 | By Aishwarya
T-Maximum Pharmaceutical Announces Latest Clinical Advances in Allogeneic CAR-T Cell Therapy
T-MAXIMUM is currently focusing on advanced-stage solid malignancies, with its lead pipeline product for recurrent high-grade glioma (rHGG) demonstrating breakthrough efficacy and manageable safety in initial clinical studies and obtained Orphan Drug Designation (ODD) from the US FDA.
CAR-T Cell Therapy | 09/08/2024 | By Aishwarya
Nona Biosciences Signs Partnership Deal with Alaya.bio to Advance CAR-T Cell Therapy
Nona Biosciences has entered into a collaboration agreement with Alaya. bio to precisely target and reprogram cells in situ and thus to significantly simplify the way CAR-T cell therapies in particular are being developed, manufactured and administered.
CAR-T Cell Therapy | 15/07/2024 | By Aishwarya | 183
Indigenously Developed CAR T-Cell Therapy Launched for Cancer Treatment in India
President Droupadi Murmu has rolled out India’s first indigenously-developed CAR T-cell therapy for the treatment of cancer.
CAR T-cell Therapy | 09/04/2024 | By Aishwarya | 262
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy